Anterior Cruciate Ligament Reconstruction With a Periosteal - Patellar Tendon - Bone Autograft - The Kocabey Press-Fit Technique
Launched by ANKARA CITY HOSPITAL BILKENT · Jan 3, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new surgical method for repairing a torn anterior cruciate ligament (ACL), which is a key ligament in the knee. The technique uses a special type of graft from the patient’s own body, called a periosteal-patellar tendon-bone autograft, and a method that doesn’t require screws or staples to fix it in place. The researchers want to see how well this new approach works compared to other existing methods, focusing on how patients feel after surgery and how quickly they can get back to their normal activities.
To participate in this study, patients should be between the ages of 18 and 75 and have had surgery to reconstruct their ACL using this specific technique. They need to have completed at least one year of follow-up care after their surgery and should not have had any further knee surgeries during that time. Participants can expect to experience less swelling and pain after the operation, along with a quicker recovery and rehabilitation process. It’s important to note that while this new technique offers potential benefits, it still carries similar risks to traditional methods.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients who underwent anatomical single-bundle anterior cruciate ligament reconstruction with periosteal - patellar tendon - bone autograft and press-fit tibial fixation technique after anterior cruciate ligament rupture
- • patients with at least 1 year of clinical and radiological follow-up
- • patients who did not undergo a revision
- Exclusion Criteria:
- • Patients who underwent a secondary arthroscopy for any reason after primary surgery
- • Patients with a history of septic arthritis (before and after the surgery)
- • Those with a history of trauma after primary surgery to the operated knee
- • Patients who have not completed at least 1 year of follow-up
About Ankara City Hospital Bilkent
Ankara City Hospital Bilkent is a leading healthcare institution in Turkey, dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Equipped with state-of-the-art facilities and a multidisciplinary team of experienced professionals, the hospital fosters a collaborative environment for conducting rigorous scientific investigations. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the highest level of integrity, ultimately contributing to the development of new therapies and enhancing the quality of care provided to patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported